p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-04-16
DOI
10.1038/s41598-019-42450-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exosome-mediated miR-200b promotes colorectal cancer proliferation upon TGF-β1 exposure
- (2018) Zhen Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Selinexor synergizes with dexamethasone to repress mTORC1 signaling and induce multiple myeloma cell death
- (2018) Christian Argueta et al. Oncotarget
- p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma
- (2016) Yiting Li et al. CANCER RESEARCH
- The non-canonical functions of p27Kip1in normal and tumor biology
- (2016) Savitha S. Sharma et al. CELL CYCLE
- Caspases uncouple p27Kip1 from cell cycle regulated degradation and abolish its ability to stimulate cell migration and invasion
- (2016) S R Podmirseg et al. ONCOGENE
- Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor
- (2016) Batzaya Davaadelger et al. Oncotarget
- Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma
- (2016) Valerie B. Sampson et al. Oncotarget
- p27 Kip1 signaling: Transcriptional and post-translational regulation
- (2015) Su Su Thae Hnit et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Pharmacodynamic and genomic markers associated with response to the XPO1/CRM1 inhibitor selinexor (KPT-330): A report from the pediatric preclinical testing program
- (2015) Edward F. Attiyeh et al. PEDIATRIC BLOOD & CANCER
- p27Kip1and STMN1: Partners again?
- (2014) George F Atweh et al. CELL CYCLE
- XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
- (2014) Giovanni Gravina et al. Journal of Hematology & Oncology
- Insulin-Like Growth Factor 1 Receptor and Response to Anti-IGF1R Antibody Therapy in Osteosarcoma
- (2014) Yu Cao et al. PLoS One
- Wee1 Inhibition by MK-1775 Leads to Tumor Inhibition and Enhances Efficacy of Gemcitabine in Human Sarcomas
- (2013) Jenny M. Kreahling et al. PLoS One
- Regulation of p27Kip1by mitogen-induced tyrosine phosphorylation
- (2012) Heidelinde Jäkel et al. CELL CYCLE
- p27Kip1 Is a Microtubule-Associated Protein that Promotes Microtubule Polymerization during Neuron Migration
- (2012) Juliette D. Godin et al. DEVELOPMENTAL CELL
- New targets and approaches in osteosarcoma
- (2012) Jonathan Gill et al. PHARMACOLOGY & THERAPEUTICS
- Prognostic Significance of Cytoplasmic p27 Expression in Human Melanoma
- (2011) G. Chen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Evaluation of eIF4E Expression in an Osteosarcoma-Specific Tissue Microarray
- (2011) Tanasa S. Osborne et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started